By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release. ![]() Factors that would cause or contribute to such differences include, but are not limited to, the Company's ability to manage expenses at sustainable levels, acceptance of the Company's products in the marketplace, the effect of global economic conditions on the ability and willingness of customers to purchase its technology, competitive factors, changes resulting from healthcare policy, dependence upon third-party vendors, timing of regulatory approvals, the impact of pandemics or other disasters, and other risks discussed in the Company's periodic and other filings with the Securities and Exchange Commission. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially. For more information, please visit This press release includes statements that may constitute "forward-looking" statements, usually containing the words "believe", "estimate", "project", "expect" or similar expressions. Stereotaxis technology has been used to treat over 100,000 patients across the United States, Europe, Asia, and elsewhere. These innovations help physicians provide unsurpassed patient care with robotic precision and safety, expand access to minimally invasive therapy, and enhance the productivity, connectivity, and intelligence in the operating room. Its mission is the discovery, development and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. Stereotaxis STXS is a pioneer and global leader in innovative surgical robotics for minimally invasive endovascular intervention. "We applaud their leadership and look forward to supporting their efforts to improve patient care and build a preeminent heart rhythm program." "We are delighted to work with Broward Health as it pioneers this technology for the benefit of patients in Florida," said David Fischel, Chairman and CEO of Stereotaxis. "We are proud to be the first in Florida to introduce this system to further enhance the comprehensive range of advanced cardiac services we deliver to our community." "Broward Health is committed to adopting innovative technology and making it available to patients close to home," said Shane Strum, President & CEO of Broward Health. When left untreated, certain arrhythmias can significantly increase the risk of stroke, heart failure, and sudden cardiac arrest. Tens of millions of individuals worldwide suffer from arrhythmias – abnormal heart rhythms that result when the heart beats too quickly, too slowly, or with an irregular pattern. ![]() The Genesis RMN system introduces the benefits of robotic precision and safety to cardiac ablation, a common, minimally invasive procedure to treat arrhythmias.
0 Comments
Leave a Reply. |